Dictionary of Cancer Terms
View in Spanish: Eculizumab
Eculizumab (ek-yoo-LY-zoo-mab)
A monoclonal antibody used to prevent red blood cells from being destroyed in patients with paroxysmal nocturnal hemoglobinuria (PNH), a red blood cell disorder. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body. Eculizumab blocks a protein in the blood that causes the breakdown of red blood cells. Also called Soliris.
Source: National Cancer Institute Dictionary of Cancer Terms, available at www.cancer.gov/dictionary.